Chemoinformaics analysis of 2,2,4-TRIMETHYL-1,2-DIHYDROQUINOLINE
| Molecular Weight | 173.259 | nRot | 0 |
| Heavy Atom Molecular Weight | 158.139 | nRig | 11 |
| Exact Molecular Weight | 173.12 | nRing | 2 |
| Solubility: LogS | -4.856 | nHRing | 1 |
| Solubility: LogP | 4.091 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 31.1419 |
| nHD | 1 | BPOL | 15.6181 |
| QED | 0.634 |
| Synth | 2.324 |
| Natural Product Likeliness | 0.12 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.363 |
| MDCK | 0.0000284 |
| BBB | 0.19 |
| PPB | 0.878198 |
| VDSS | 2.073 |
| FU | 0.115939 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.942 |
| CYP2c19-inh | 0.916 |
| CYP2c19-sub | 0.718 |
| CYP2c9-inh | 0.67 |
| CYP2c9-sub | 0.798 |
| CYP2d6-inh | 0.912 |
| CYP2d6-sub | 0.901 |
| CYP3a4-inh | 0.453 |
| CYP3a4-sub | 0.352 |
| CL | 4.469 |
| T12 | 0.455 |
| hERG | 0.028 |
| Ames | 0.017 |
| ROA | 0.13 |
| SkinSen | 0.877 |
| Carcinogencity | 0.22 |
| EI | 0.983 |
| Respiratory | 0.868 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.734594 |